发明申请
- 专利标题: TARGETING VECTOR-PHOSPHOLIPID CONJUGATES
- 专利标题(中): 靶向载体 - 磷脂结合体
-
申请号: US13948505申请日: 2013-07-23
-
公开(公告)号: US20140031520A1公开(公告)日: 2014-01-30
- 发明人: Philippe BUSSAT , Samir Cherkaoui , Hong (Helen) Fan , Bernard Lamy , Palaniappa Nanjappan , Radhakrishna K. Pillai , Sibylle Pochon , Bo Song , Rolf E. Swenson
- 申请人: BRACCO SUISSE SA
- 申请人地址: CH Manno
- 专利权人: Bracco Suisse SA
- 当前专利权人: Bracco Suisse SA
- 当前专利权人地址: CH Manno
- 主分类号: C07K14/00
- IPC分类号: C07K14/00
摘要:
Peptide vectors having high KDR binding affinity and processes for making such vectors are provided. The peptide vectors may be conjugated to phospholipids and included in ultrasound contrast agent compositions. Such ultrasound contrast agents are particularly useful in therapeutic and diagnostic methods, such as in imaging KDR-containing tissue and in the evaluation and treatment of angiogenic processes associated with neoplastic conditions. The present invention also provides processes for the large scale production of highly pure dimeric and monomeric peptide phospholipid conjugates as well as precursor materials used to form the conjugates. The present invention further provides processes for the large scale production of highly pure peptide phospholipid conjugates which contain very low levels of TFA.
公开/授权文献
- US09381258B2 Targeting vector-phospholipid conjugates 公开/授权日:2016-07-05
信息查询